CancerFACTORNCT07390435
Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials
An observational study of Cancer, run by Canadian Cancer Trials Group at 15 sites in Canada.
Trial summary
This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cancer
- What is being tested?
- Social Determinants of Health Questionnaire
- How many people
- 1,000 participants
- Where
- 15 sitesCanada
- Study dates
- 15 May 2026to 30 Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study is designed to include participants who have consented to a CCTG clinical trial. If a patient consents to a CCTG trial but does not enroll, they will remain eligible for SC.32S.
Who may be able to join
- Adults (≥18 years) who are either:
- Currently being screened and consented to a CCTG trial (prospective).
- Already enrolled in an ongoing CCTG trial and still under follow-up (retrospective).
Who cannot join
- Participants already enrolled or expected to enroll in a CCTG trial that is also collecting the SDoH Questionnaire.
Trial locations and contacts
15 sites in 1 country. Contact the study team or a site near you to ask about taking part.
15 sites in 1 country
Canada15 sites, 15 recruiting
- Recruiting
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2
Marc Kerba, 403 521-3164
- Recruiting
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2
Ericka Wiebe, 780 432-8755
- Recruiting
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2
Courtney Coschi
- Recruiting
BCCA - Kelowna
Kelowna, British Columbia, V1Y 5L3
Katie Jasper, 250 712-3900
- Recruiting
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7
April Swoboda, 613 544-2361
- Recruiting
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6
Moira Rushton
- Recruiting
BCCA - Prince George
Prince George, British Columbia, V2M 7E9
Andre Gouveia
- Recruiting
CHA-Hopital Du St-Sacrement
Québec, Quebec, G1S 4L8
Claudya Morin, 418 682-7511
- Recruiting
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1
Ayesha Bashir, 306 766-2691
- Recruiting
Regional Health Authority B, Zone 2
Saint John, New Brunswick, E2L 4L2
Anthony J. Reiman, 506 648-6884
- Recruiting
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4
Shahid Ahmed, 306 655-2710
- Recruiting
Algoma District Cancer Program
Sault Ste. Marie, Ontario, P6B 0A8
Silvana Spadafora, 705 759-3434 ext. 4450
- Recruiting
Odette Cancer Centre
Toronto, Ontario, M4N 3M5
Amandeep Taggar, 416 480-6165 ext. 2804
- Recruiting
BCCA - Vancouver
Vancouver, British Columbia, V5Z 4E6
Leah Lambert, 604 877-6000
- Recruiting
BCCA - Victoria
Victoria, British Columbia, V8R 6V5
Caroline Holloway, 250 519-5609
About this study
This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.
Read the detailed description
It is anticipated that 1000 people will take part in this study. Participation in this study will only take about 10 minutes or less. Participants who choose to take part in this study will be asked to fill out a form with questions in English or French about the non-medical factors that influence health. This includes asking about the conditions and places in which the participant lives, learns, works, and plays. Participants will also be asked how they feel about answering these questions. Researchers will use this information to better understand who participates in clinical trials.
- Conditions
- Cancer
- Being tested
- Social Determinants of Health Questionnaire
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Social Determinants of Health QuestionnaireOther
This study will use a standardized SDoH Questionnaire to collect the required sociodemographic data
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial
Measured: 12 months
Secondary outcomes (1)
To assess the acceptability of this SDoH questionnaire to participants.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2026
- Study start15 May 2026
- Primary completion31 Jan 2027 (estimated)
- Study completion30 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by Canadian Cancer Trials GroupThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Other
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Canadian Cancer Trials Group
- Sponsor type
- Research network
- Responsible party
- Sponsor
- Investigators
- Leah Lambert, Study chair, BCCA - Vancouver Cancer Centre, Vancouver, BC CanadaMichael McKenzie, Study chair, BCCA - Vancouver Cancer Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07390435
- Sponsor's protocol ID
- SC32S
- Acronym
- FACTOR
- Status last verified
- Jun 2026
- First submitted
- 29 Jan 2026
- Last updated
- 14 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials
- ClinicalTrials.gov ID
- NCT07390435
- Acronym / sponsor ID
- FACTOR / SC32S
- Conditions
- Cancer
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Canadian Cancer Trials GroupResearch network
- Study start
- 15 May 2026 (actual)
- Primary completion
- 31 Jan 2027 (estimated)
- Study completion
- 30 Jun 2027 (estimated)
- First posted
- 5 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.
Detailed description
It is anticipated that 1000 people will take part in this study. Participation in this study will only take about 10 minutes or less. Participants who choose to take part in this study will be asked to fill out a form with questions in English or French about the non-medical factors that influence health. This includes asking about the conditions and places in which the participant lives, learns, works, and plays. Participants will also be asked how they feel about answering these questions. Researchers will use this information to better understand who participates in clinical trials.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study is designed to include participants who have consented to a CCTG clinical trial. If a patient consents to a CCTG trial but does not enroll, they will remain eligible for SC.32S.
Key inclusion criteria (3 listed)
- Adults (≥18 years) who are either:
Key exclusion criteria (1 listed)
- Participants already enrolled or expected to enroll in a CCTG trial that is also collecting the SDoH Questionnaire.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Social Determinants of Health QuestionnaireThis study will use a standardized SDoH Questionnaire to collect the required sociodemographic data | Other | – |
Primary outcome
To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial
Time frame: 12 months
1 secondary outcome
To assess the acceptability of this SDoH questionnaire to participants.
Time frame: 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Cancer
Recruiting
MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer
Lung Neoplasms, Neoadjuvant Therapy
Active, not recruitingPhase 2
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7
Not yet recruitingPhase 2
A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia
Cachexia-Anorexia Syndrome, Cachexia; Cancer
RecruitingPhase 2
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
Esophageal Squamous Cell Carcinoma, Immunotherapy
Not yet recruitingPhase 1/2
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Leah Lambert study chair
BCCA - Vancouver Cancer Centre, Vancouver, BC Canada
Michael McKenzie study chair
BCCA - Vancouver Cancer Centre
15 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by Canadian Cancer Trials Group at 15 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 15 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Anna Johnson (613-533-6430, ajohnson@ctg.queensu.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2026.